| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ORIGINAL ARTICLES |
From the ENRICHD Coordinating Center, Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina. ENRICHD investigators are listed in the Appendix.
Address reprints requests to: The ENRICHD Coordinating Center, University of North Carolina, Department of Biostatistics, CB#8030, Collaborative Studies Coordinating Center, 137 East Franklin Street, Suite 203, Chapel Hill, NC 27514-4145.
OBJECTIVE: Depression and low social support are risk factors for medical morbidity and mortality after acute MI. The ENRICHD study is a multicenter, randomized, controlled clinical trial of a cognitive-behavioral treatment for depression and low social support in post-MI patients. A total of 2481 patients were recruited (26% with low social support, 39% with depression, and 34% with low social support and depression). Our objective is to describe the rationale, design, and delivery of the ENRICHD intervention.
METHODS: Key features of the intervention include the integration of cognitive-behavioral and social learning approaches to the treatment of depression and a diverse set of problems that can contribute to low social support; rapid initiation of treatment after MI; a combination of individual and group modalities; adjunctive pharmacotherapy for severe or intractable depression; training, certification, and supervision of therapists; and quality assurance procedures.
RESULTS: The trial’s psychosocial and medical outcomes will be presented in future reports.
CONCLUSIONS: The ENRICHD protocol targets two complex psychosocial risk factors with a multifaceted intervention, which is delivered in an individualized manner to accommodate a demographically, medically, and psychiatrically diverse patient population. Additional research will be needed to identify optimal matches between patient characteristics and specific components of the intervention.
Key Words: myocardial infarction • coronary heart disease • depression • social support • clinical trials
Abbreviations: ENRICHD = Enhancing Recovery in Coronary Heart Disease Patients;; MI = myocardial infarction;; CHD = coronary heart disease;; CAD = coronary artery disease;; CBT = cognitive behavior therapy;; DISH = depression interview and structured Hamilton;; DIS = diagnostic interview schedule;; LPSS = low perceived social support;; BDI = Beck Depression Inventory;; SSRI = selective serotonin reuptake inhibitor;; PSSS = Perceived Social Support Scale.
This article has been cited by other articles:
 |
|
 |
|
  W. Linden, M. J. Phillips, and J. Leclerc Psychological treatment of cardiac patients: a meta-analysis Eur. Heart J., December 2, 2007; 28(24): 2972 - 2984. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Lesperance, N. Frasure-Smith, D. Koszycki, M.-A. Laliberte, L. T. van Zyl, B. Baker, J. R. Swenson, K. Ghatavi, B. L. Abramson, P. Dorian, et al. Effects of Citalopram and Interpersonal Psychotherapy on Depression in Patients With Coronary Artery Disease: The Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) Trial JAMA, January 24, 2007; 297(4): 367 - 379. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Lustman, R. E. Clouse, B. D. Nix, K. E. Freedland, E. H. Rubin, J. B. McGill, M. M. Williams, A. J. Gelenberg, P. S. Ciechanowski, and I. B. Hirsch Sertraline for Prevention of Depression Recurrence in Diabetes Mellitus: A Randomized, Double-blind, Placebo-Controlled Trial. Arch Gen Psychiatry, May 1, 2006; 63(5): 521 - 529. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Frasure-Smith, D. Koszycki, J. R. Swenson, B. Baker, L. T. van Zyl, M.-A. Laliberte, B. L. Abramson, J. Lambert, G. Gravel, and F. Lesperance Design and Rationale for a Randomized, Controlled Trial of Interpersonal Psychotherapy and Citalopram for Depression in Coronary Artery Disease (CREATE) Psychosom Med, January 1, 2006; 68(1): 87 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Dickens, L. McGowan, C. Percival, J. Douglas, B. Tomenson, L. Cotter, A. Heagerty, and F. Creed Association Between Depressive Episode Before First Myocardial Infarction and Worse Cardiac Failure Following Infarction Psychosomatics, December 1, 2005; 46(6): 523 - 528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Burg, J. Barefoot, L. Berkman, D. J. Catellier, S. Czajkowski, P. Saab, M. Huber, V. DeLillo, P. Mitchell, J. Skala, et al. Low Perceived Social Support and Post-Myocardial Infarction Prognosis in the Enhancing Recovery in Coronary Heart Disease Clinical Trial: The Effects of Treatment Psychosom Med, November 1, 2005; 67(6): 879 - 888. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. B. Taylor, M. E. Youngblood, D. Catellier, R. C. Veith, R. M. Carney, M. M. Burg, P. G. Kaufmann, J. Shuster, T. Mellman, J. A. Blumenthal, et al. Effects of Antidepressant Medication on Morbidity and Mortality in Depressed Patients After Myocardial Infarction Arch Gen Psychiatry, July 1, 2005; 62(7): 792 - 798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. W. Davidson, N. Rieckmann, and M. A. Rapp Definitions and Distinctions Among Depressive Syndromes and Symptoms: Implications for a Better Understanding of the Depression-Cardiovascular Disease Association Psychosom Med, May 1, 2005; 67(Supplement_1): S6 - S9. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. S. Lett, J. Davidson, and J. A. Blumenthal Nonpharmacologic Treatments for Depression in Patients With Coronary Heart Disease Psychosom Med, May 1, 2005; 67(Supplement_1): S58 - S62. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Carney, J. A. Blumenthal, K. E. Freedland, M. Youngblood, R. C. Veith, M. M. Burg, C. Cornell, P. G. Saab, P. G. Kaufmann, S. M. Czajkowski, et al. Depression and Late Mortality After Myocardial Infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) Study Psychosom Med, July 1, 2004; 66(4): 466 - 474. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Schneiderman, P. G. Saab, D. J. Catellier, L. H. Powell, R. F. DeBusk, R. B. Williams, R. M. Carney, J. M. Raczynski, M. J. Cowan, L. F. Berkman, et al. Psychosocial Treatment Within Sex by Ethnicity Subgroups in the Enhancing Recovery in Coronary Heart Disease Clinical Trial Psychosom Med, July 1, 2004; 66(4): 475 - 483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Schrader, F. Cheok, A.-L. Hordacre, and N. Guiver Predictors of Depression Three Months After Cardiac Hospitalization Psychosom Med, July 1, 2004; 66(4): 514 - 520. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. S. Lett, J. A. Blumenthal, M. A. Babyak, A. Sherwood, T. Strauman, C. Robins, and M. F. Newman Depression as a Risk Factor for Coronary Artery Disease: Evidence, Mechanisms, and Treatment Psychosom Med, May 1, 2004; 66(3): 305 - 315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Writing Committee for the ENRICHD Investigators Effects of Treating Depression and Low Perceived Social Support on Clinical Events After Myocardial Infarction: The Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial JAMA, June 18, 2003; 289(23): 3106 - 3116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Frasure-Smith and F. Lesperance Depression--A Cardiac Risk Factor in Search of a Treatment JAMA, June 18, 2003; 289(23): 3171 - 3173. [Full Text] [PDF]
|
|
|
|
 |
|
 B. C. Sirois and M. M. Burg Negative Emotion and Coronary Heart Disease: A Review Behav Modif, January 1, 2003; 27(1): 83 - 102. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
